Trial NCT04184518

View at ClinicalTrials.gov 
Org. Study IDs: GEM-1805
Secondary IDs: 2019-001045-40 ESR-18-14002

Last trial update was posted on 2020-06-02

MeSH Interventions

Cediranib Durvalumab

MeSH Conditions

Melanoma Uveal Neoplasms

Other Conditions

Metastatic Cancer Uveal Melanoma

Stopping Reasons

The Cediranib producer laboratory decided to stop the development of this product.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID